Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3359 Target Snapshot

fMet-Leu-Phe receptor · SINGLE PROTEIN · Homo sapiens

1,308Compounds
128Assays
9Approved Drugs
1,612.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P21462. Use UniProt P21462 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P21462 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats fMet-Leu-Phe receptor as ChEMBL target CHEMBL3359, mapped to UniProt P21462. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
fMet-Leu-Phe receptor
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3359
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P21462
fMet-Leu-Phe receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether fMet-Leu-Phe receptor is the right protein anchor across sources, using UniProt P21462 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelfMet-Leu-Phe receptor
UniProt AccessionP21462
Component TypeProtein
Sequence Length350 aa

fMet-Leu-Phe receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as fMet-Leu-Phe receptor, mapped to UniProt P21462. Sequence length is 350 aa.

Mapped IDP21462
Review namefMet-Leu-Phe receptor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

9
Approved
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50276.0
KI286.0
EC501,007.0
KD43.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5567096 9.3 EC50 0.5 Preclinical
CHEMBL5543029 9.25 EC50 0.56 Preclinical
CHEMBL5276622 9.24 EC50 0.58 Preclinical
CHEMBL5558209 9.23 EC50 0.59 Preclinical
CHEMBL7753 9.0 EC50 1.0 Preclinical
CHEMBL267388 9.0 EC50 1.0 Preclinical
CHEMBL5267736 9.0 EC50 1.0 Preclinical
CHEMBL5275766 9.0 EC50 1.0 Preclinical
CHEMBL5276203 9.0 EC50 1.0 Preclinical
CHEMBL5278464 9.0 EC50 1.0 Preclinical
Distribution

pChEMBL Value Distribution

157
5.0
188
5.5
242
6.0
175
6.5
109
7.0
65
7.5
30
8.0
16
8.5
20
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

LOPERAMIDE HYDROCHLORIDE
CHEMBL1707
Approved 1976
Assay Landscape

Assay Landscape

128
Total Assays
471
Tested Compounds
2
Assay Types
Functional — 81 assays, 471 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 59 293 6.0
assay format 18 166 5.2
single protein format 3 10 5.3
tissue-based format 1 2 6.7
Binding — 47 assays, 398 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 31 320 6.6
single protein format 15 23 6.8
assay format 1 55 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine